Biologics can be highly effective for patients with juvenile idiopathic arthritis (JIA), but that effectiveness comes at a high annual cost, researchers from Canada report in the August 25th online advance issue of Arthritis Care & Research. Reuters Health Information
Studies show that the risk of heart attack is higher in patients with rheumatoid arthritis, as is the rate of heart failure ARTHRITIS & RHEUMATISM Research News Alerts
Regular monitoring and treating to a DAS-28 score of less than 2.6 produces better RA outcomes than not monitoring DAS-28 or the HAQ-Disability Index score. Medscape Medical News
In patients with ankylosing spondylitis, infliximab does not inhibit structural damage, although it may have other beneficial effects, according to European and US researchers. Reuters Health Information
Join Dr. Kay in an in-depth discussion of the latest advances in mechanism-based treatment options for patients with RA who are refractory to treatment. Medscape Rheumatology